Back

3-Year outcomes from the comparison of amulet and watchman/FLX device in patients undergoing left atrial appendage closure: the SWISS-APERO randomized clinical trial

30 March 2025 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Late-Breaking Science: clinical / stroke Left Atrial Appendage Closure EHRA Premium Access EHRA 2025 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Roberto Galea

University Hospital, Bern (Switzerland)

11 More presentations in this session

Presentation thumbnail
Worldwide incidence, management and outcome of systemic embolism following atrial fibrillation ablation: preliminary results from the EMBOL-AF registry.
Doctor S. Castrejon Castrejon (Madrid, ES)
Slides Video
Presentation thumbnail
Discussant review - EMBOL-AF
Professor J. Kalman (Melbourne, AU)
Slides Video
Presentation thumbnail
Discussion - EMBOL-AF
Video
Presentation thumbnail
Discussant review - SWISS-APERO
Professor O. wazni (Cleveland, US)
Video
Presentation thumbnail
Discussion - SWISS-APERO
Video

Access the full session

Session thumbnail
Late-Breaking Science: clinical / stroke
Video

The Event

Event poster

EHRA 2025

30 March - 1 April 2025
You may be interested in
thumbnail
Congress Presentation
Discussion - SWISS-APERO
thumbnail
Congress Presentation
Discussion - EMBOL-AF
thumbnail
Congress Presentation
Randomized comparison of left atrial appendage closure and oral anticoagulation after catheter ablation for atrial fibrillation: subanalysis of AF type

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources